3 Results for "

SU-DHL-4 DLBCL cells

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "SU-DHL-4 DLBCL cells" in MCE Product Catalog:

Cat. No.: HY-161989
CAS No.: 3105664-95-4
Target:  

PROTACs BCL6 PAK

Research Areas:  

Cancer

DZ-837 is a BCL6 PROTAC degrader with a DC50 of 557.7 nM. DZ-837 induces BCL6 ubiquitination and degradation in a CRBN-dependent manner via the ubiquitin-proteasome system. DZ-837 activates CDKN1A and CDKN1B, the downstream genes of BCL6. DZ-837 upregulates p21 and p27 proteins . DZ-837 inhibits tumor growth in a diffuse large B-cell lymphoma xenograft mouse model. DZ-837 exerts synergistic antiproliferative effects when combined with Ibrutinib (HY-10997). DZ-837 can be used in studies related to diffuse large B-cell lymphoma .
loading...
    loading...
Cat. No.: HY-177755
CAS No.: 2230406-52-5
Target:  

Molecular Glues BCL6

Research Areas:  

Cancer

BCL6-IN-10 is a molecular glue inhibitor targeting the BCL6 BTB domain with an IC50 of 4 nM. BCL6-IN-10 blocks the interaction between BCL6 and transcriptional co-repressors, and induces partial degradation of BCL6 via the ubiquitin-proteasome pathway, thereby de-repressing BCL6 target genes and inhibiting cancer cell proliferation. BCL6-IN-10 can be used in the research of diffuse large B-cell lymphoma .
loading...
    loading...
Cat. No.: HY-177756
CAS No.: 2230406-60-5
Target:  

BCL6

Research Areas:  

Cancer

BCL6-IN-11 is a potent inhibitor of the BCL6 BTB domain and a partial degrader of BCL6. BCL6-IN-11 inhibits the interaction between the BCL6 BTB domain and BCOR with an IC50 of 6 nM. BCL6-IN-11 can be used for research related to BCL6 degradation in diffuse large B-cell lymphoma (DLBCL) .
loading...
    loading...